ATHEROSCLEROSIS TRIALS : APPROVAL, IMPLEMENTATION AND REIMBURSEMENT CHALLENGES
- Dec 1, 2020
- 1 min
Making CV Precision Medicine Become a Reality
- Nov 27, 2020
- 2 min
Pathways to Enhance Biomarker Value – Imagining Innovation
- Nov 26, 2020
- 2 min
Iron Therapy in Heart Failure: From Trial Evidence to Implementation
- Nov 26, 2020
- 2 min
The Future of HFrEF Trials
- Nov 26, 2020
- 2 min
iCVCT 8: TAVR Trials. Remaining Questions, Challenges, Controversies in Approval Pathways
- Nov 25, 2020
- 2 min
iCVCT 7. STEMI Trials
- Nov 25, 2020
- 2 min
iCVCT 6. Shock and STEMI Trials - Hemodynamic Support in Shock
- Nov 25, 2020
- 2 min
How Are Payers Prepared To Value Clinical Evidence In Cardiovascular Medicine?
- Nov 24, 2020
- 2 min
Increasing Healthspan: the Next Frontier for Clinical Trialists
- Nov 24, 2020
- 2 min
iCVCT 5. Breakthrough Heart Failure Devices
- Nov 24, 2020
- 1 min
CKD and Cardio-Kidney Trials Seeing the Forest for the Trees
- Nov 23, 2020
- 2 min
Targeting the Vessels and the Heart: Oral Soluble Guanylate Cyclase Stimulator and (...)
- Nov 23, 2020
- 2 min
“Nullius in Verba” the Crisis of the Experimental Paradigm during the COVID-19 Pandemic
- Nov 23, 2020
- 2 min
iCVCT 4. DAPT Considerations in Patients Post-PCI Trials
- Nov 23, 2020
- 2 min
iCVCT 3. Coronary Intervention Trials Complex Patients- Complex Lesions Trials
- Nov 22, 2020
- 2 min
iCVCT 2. Mitral and Tricuspid Valve Devices Trials
- Nov 22, 2020
- 2 min
Cardiomyopathies: Part 1 and 2
- Nov 22, 2020
- 1 min
iCVCT 1. Interventional Clinical Trials in the Time of COVID: Challenges (...)
- Nov 22, 2020
- 3 min
Atherosclerosis: Parts 1, 2, and 3